Archive for the ‘Strategic Plan’ Category

Trade Mission to 2017 Zhejiang Medical Expo

May 25, 2017

Turnpike Trade Mission
Zhejiang Medical Equipment Expo/Health Services Promotion Expo
Zhejiang Province, China
September 10-17, 2017

Hangzhou ExpoThe Hangzhou International Expo Center will be the main venue for the 2017 Health Expo in Hangzhou, the capital of Zhejiang province.(Photo/Xinhua)

The state trade association members of the Turnpike Partnership and their members are invited to participate in a trade mission to Zhejiang Province, China. Coordinated by the Indiana Health Industry Forum (IHIF) and their agent in China, Pacific World Trade (PWT), the mission will attend the “2017 Health Expo”, a joint meeting of the Zhejiang Medical Equipment Expo and the Health Services Promotion Expo. The exhibition and conference will be held in the newly appointed G-20 conference center in Hangzhou, Zhejiang, China.

Mission Focus

Expo 2

The Medical Products Exhibition provides procurement units across many different hospital and healthcare facility levels with an efficient and convenient platform
for viewing new devices and technologies.

This mission will focus on making introductions and developing commercial partnerships in China for U.S. companies engaged in the design, development, appointment/outfitting of hospitals and healthcare facilities, and related training and services.

  • Facility design and operation
  • Digital technologies
  • Hospital Equipment and Supplies
  • Training (healthcare and equipment)
  • Services

Mission Services
Companies participating in the mission will be provided with 1:1 meetings coordinated by PWT and the Zhejiang Health Services Promotion Council, a presentation opportunity to conference attendees, and participation in a Turnpike booth at the Expo.

Agenda*
September 10 – Depart US
September 11 – Arrive in Hangzhou, Zhejiang Province.
September 12 – Briefing/reception, potential for pre-arranged meetings/tours
September 13 – 16 – 2017 Healthcare Expo: exhibition, presentations, meetings
September 17 – Return to U.S.
*subject to change depending on availability

Mission fees and registration
Delegates are responsible for their own travel/accommodation arrangements. There will be a reserved block of hotel rooms for the mission, near the exhibition center. PWT will provide assistance with letters of invitation for visas, and have staff available on the ground in China. Other anticipated costs may include in-country transportation and translation services.

Mission participation fee: $2,995/organization*
*Mission fee subject to change. Rate includes shared costs for a 3mX3m Turnpike exhibition booth and rental of facilities for company presentations. Requires a minimum of four company participants.

Registration Deadline: August 1, 2017
For more information or to register for the mission, please contact the Indiana Health Industry Forum at info@ihif.org.  Download Mission Brochure.  Download 2017 ZIHIE Brochure.

About Zhejiang: Zhejiang province is located on the southeast coast of China, to the south of Shanghai. It is divided into eleven prefecture-level divisions, nine prefecture level cities and two sub-provincial cities (the capital city of Hangzhou and city of Ningbo). Zhejiang is considered a relatively wealthy province and has been consistently in the top 5 out of 34 provinces in terms of nominal total GDP and GDP per capita. In 2015, it contributed 7% of China’s total GDP. Zhejiang has a population of 55 million people with 1,049 hospitals across the province.

Zhejiang province is the largest consumer of medical devices in China and serves as a “showcase” for the total market. 30,000 professionals will attend the Expo. The annual transaction value at the Expo is over $175 million or about 20% of the total market value.

About the Conference: After two successful ZIHIE Expos, in September 2017, a more comprehensive and innovative Expo will be held at the new Hangzhou International Expo Center. With hundreds of exhibitors and thousands of their products and services from across the world, ZIHIE has become the largest health brand exposition for Zhejiang province. 800 hospitals will be represented by executive staff as part of the provincial Hospital Association annual meeting.

About IHIF/PWT: The Indiana Health Industry Forum and Pacific World Trade work together to help Indiana health science companies explore market opportunities in China and specifically work with governmental and private organizations in Zhejiang Province, Indiana’s sister-state. Leveraging the 30+ year relationship PWT has fostered on behalf of Indiana, combined with export guidance and counseling, member companies of IHIF can be assured of a well-researched and supported introduction to the Chinese market.

About the Turnpike Partnership: The Turnpike Partnership is an international network of health science industry associations focused on patient-driven public policy and innovation services. The Turnpike Partnership brings together health science associations and their members with industry leaders, research universities, startup companies, mentors, and related national trade associations. The Turnpike model erases geo-political boundaries and focuses on getting innovation in front of the people who can connect it most quickly to patients. Organized and led at the state/grassroots level, the Partnership provides a collaborative, viable, sustainable business model and support system.

Advertisements

IHIF Signs Partnership Agreement With Scottish Lifesciences Association

May 17, 2017

 Builds New Market Opportunities for State Industry Members

Contact: Kristin Jones, IHIF, kjones@ihif.org +1-317-752-9809

(Indianapolis,IN USA and Edinburgh, Scotland UK- May 16, 2017) — The Indiana Health Industry Forum (IHIF) and the Scottish Lifesciences Association (SLA) have signed a Memorandum of Understanding to share member benefits between the two organizations.  IHIF and SLA share the same essential vision with regards to creation and maintenance of an environment that nurtures and supports life sciences companies.  The objectives are to foster innovation and valuable, dynamic links between US-based member companies of IHIF and Scotland-based member companies of SLA.

 

According to Scott Johnstone, CEO of the SLA, “IHIF and SLA intend to represent the USA and EU to each other as practical for the mutual benefit of our organizations and our member companies.  Through this relationship, we intend to increase the visibility, sales, investment, regulation, and innovation prospects for our member companies”.

 

Both organizations are members of the multi-state Turnpike Partnership, an innovation-driven network of resources and organizations built to support and enhance the life sciences industry. Scotland is a key international partner with a life sciences cluster of similar size and scope to Indiana’s.

 

Building on an already strong trade relationship, “IHIF and SLA were able to come together through the Turnpike Partnership and build an alliance that will directly benefit our members”, said Kristin Jones, President and CEO of IHIF.  “The partnership with SLA is a further expansion of our international network and will give our members strategic access to UK and European markets at a time of dynamic change.  We also look forward to working with members of SLA as they build their business networks and explore opportunities in the U.S.”

 

The MOU was signed at the 2017 Derby Summit, an annual event for the Kentucky Life Sciences Council.  The Scottish delegation also visited Boston and IHIF representatives attended the May 11 Spring Members Meeting for the SLA in Glasgow, Scotland.

 

About SLA

With 135 member companies and organisations, the SLA is the voice of Scotland’s vibrant life sciences industries to investors, NHSScotland, the Scottish and UK Governments, and the wider community.  The SLA is driven by and network with its members through 14 Special Interest Groups and 4 sub-groups.  The SLA helps to grow members’ businesses, and engage with the NHS and Government to grow the life sciences sector in Scotland.

 

For more information: http://www.scottishlifesciencesassociation.org.uk

 

About IHIF

IHIF is a statewide trade association representing Indiana’s health science business community.  The diverse members of the Indiana Health Industry Forum generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.

 

For more information: http://www.ihif.org

SLA Mou

Kristin Jones (IHIF) and Scott Johnstone (SLA) sign agreement to trade member services.

###

IHIF is a Proud Partner in National Health IT Week

August 21, 2016

This September, IHIF — as a partner in the advancement of health information technology to help improve healthcare —is a Proud Partner in National Health IT Week.  National Health IT Week is the premier event offering all healthcare stakeholders an opportunity to unite under one banner, expressing the benefits that health information technology (IT) brings to U.S. healthcare. “The Value of Health IT.”

Comprehensive health care reform is not possible without system-wide adoption of health information technology, which improves the quality of healthcare delivery, increases patient safety, decreases medical errors, and strengthens the interaction between patients and healthcare providers.

With Meaningful Use now providing the way forward, eligible providers across the country increasingly understand the benefits for themselves and their patients, and are adopting Meaningful Use compliant electronic health records.

Initiated in 2006 by the Healthcare Information and Management Systems Society (HIMSS), National Health IT Week has emerged as a landmark occasion for using health IT as part of the overall solution to improve America’s healthcare as a bipartisan, federally led, market driven initiative.

The Week consists of events across the country, including National Health IT Weekparticipants —vendors, provider organizations, payers, pharmaceutical/biotech companies, government agencies, industry/professional associations, research foundations, and consumer protection groups— all working together to elevate national attention to the advantages of advancing health IT.

View our full list of partners and updates on the Week’s events. Working together with our growing coalition of stakeholders, IHIF is helping to transform healthcare for all.

Ivy Tech Bloomington led development of national educational skill standard for medical device careers

August 9, 2016

 

FOR IMMEDIATE RELEASE

August 9, 2016

 

Contact:  Amanda Billings

Executive Director, Marketing/Communications

Ivy Tech Community College – Bloomington

(812) 330-6222   |   abillings7@ivytech.edu

 

BLOOMINGTON – Ivy Tech Community College’s Bloomington campus led a consortium of 12 other community colleges and 72 medical device industry partners nationwide to develop the nation’s first skill set standards for entry-level medical device jobs in the U.S. The Community College Consortium for Bioscience Credentials (c3bc) published “Medical Device Skill Standards,” a manual of educational guidelines to ensure educators and trainers develop and teach the skills needed in entry level medical device jobs in the U.S. The project was funded by a $15 million dollar grant from the U.S. Department of Labor.

 

Sengyong Lee, Ph.D., professor and Ivy Tech Bloomington biotechnology program chair, is c3bc’s medical device hub leader. Dr. Lee and his team at Ivy Tech Bloomington led the nationwide collaboration. “The advancement of medical technology and growing health care needs for elderly populations around the globe have accelerated the growth of companies like Cook Medical in recent decades,” Dr. Lee said. “The medical device industry is in need of a continuous pipeline of skilled workers to meet their growth demands. Our partners and educators who developed the skill standards manual hope for a long-term return on investment in the form of graduates from community colleges who will fill those jobs.”

 

Local employers, including Chapman Lake Instrument Corp., Cook Medical, Cook Polymer Technology, and Boston Scientific Corporation, participated as industry partners. Employers outlined skills needed in entry-level medical device positions, which educators used to create skill standards for teaching and testing students.

 

Educators nationwide have already begun to use the skill standards manual to create new and revise educational courses, certificates, and degrees to align with industry needs. For example, Ivy Tech Bloomington developed a new medical device quality certificate that counts toward the biotechnology associate degree and leads to a career in the industry. Ivy Tech Bloomington also has a plastics program and regulatory affairs certificate to meet local employer needs.

 

In addition to publishing the manual, c3bc also developed ‘Courses in a Box’ which educators nationwide can use to develop curriculum. The downloadable, digital materials outline exactly what should be taught, and includes everything a credentialed instructor would need to teach the course online or in person.

 

“The courses in a box project will be especially valuable to educators and trainers who are new in the field. Of course, the main beneficiaries of the project are the students and trainees who will receive valuable education,” Dr. Lee said.

 

The c3bc’s Medical Device Skill Standards manual and Courses in a Box are now published and are free and available to download. The standards manual can be found online at

https://www.skillscommons.org/handle/taaccct/8777 and the Courses in a Box can be found at

https://www.skillscommons.org/handle/taaccct/442.

 

For information about Bloomington programs in medical device manufacturing, plastics, and biotechnology, visit ivytech.edu/biotechnology and click Bloomington. Fall classes begin August 22 but students should enroll by August 12 in order to be prepared on the first day of classes. To enroll, visit www.ivytech.edu/applynow, stop into Ivy Tech Bloomington located at 200 Daniels Way, or call (812) 330-6013.

 

About Ivy Tech Community College
Ivy Tech Community College (www.ivytech.edu) is the state’s largest public postsecondary institution and the nation’s largest singly accredited statewide community college system.  Ivy Tech has campuses throughout Indiana. It serves as the state’s engine of workforce development, offering affordable degree programs and training that are aligned with the needs of its community along with courses and programs that transfer to other colleges and universities in Indiana. It is accredited by the Higher Learning Commission and a member of the North Central Association.

 

###

 

Interview contacts:

 

Dr. Sengyong Lee
812-330-6036

slee@ivytech.edu

 

Chris Kilander

Global Product Manager/Team Leader – Peripheral Intervention

Cook Incorporated

750 Daniels Way

Bloomington, IN 47404

1-800-468-1379 ext. 10-1978

Mobile: 812-322-8097

Chris.Kilander@CookMedical.com

 

Kathy Heuer,

Executive Director, Indiana Medical Device Manufacturing Council, Inc.

Kathy Heuer

Executive Director, IMDMC, Inc.

PO Box 441385

Indianapolis, IN 46244

(260) 609-2802

imdmc@imdmc.org

 

IHIF Announces Legislators of the Year

May 16, 2016

Recognizes those making significant policy impact on the state’s health science sector

Contact: Kristin Jones, President and CEO
Indiana Health Industry Forum
kjones@ihif.org or 317-686-0994

INDIANAPOLIS, IN (May 16, 2016) — In conjunction with its 2016 Annual Meeting, the Indiana Health Industry Forum (IHIF) recognized U.S. Representative Larry Bucshon, M.D., and State Senator Patricia Miller as the IHIF 2016 Legislators of the Year.  “Each year we recognize federal and state legislators who have demonstrated a commitment to excellence in public health policy and service to Indiana’s health science business community”, said Kristin Jones, President and CEO of IHIF.  “This year we are so pleased to be able to recognize both Representative Bucshon for his work and leadership on the Congressional 21st Century Cures Initiative and Senator Miller for her dedication to health issues and 30 years of public service”.

 

Prior to being elected to Congress, Representative Bucshon spent his career specializing in cardiothoracic surgery and has performed hundreds of heart surgeries.  As one of only a few practicing physicians in Congress his experience with all aspects of health care delivery afford him unique insight and perspective on efforts to improve patient care and seek value across the health care spectrum.  He has been an educated voice of opposition to a proposed CMS rule that would implement a new Medicare Part B drug payment model that would negatively affect patient access to essential medication and treatment therapies.   He has also been a leader in the fight against opioid abuse, working with Representative Paul Tonko (D-NY) to introduce, “The Opioid Use Disorder Treatment Expansion and Modernization Act”.

 

Senator Patricia Miller announced earlier this year that she would be retiring from the state legislature after more than 30 years.  Her outstanding efforts as Chair of the Senate Committee on Health and Provider Services have led to policies that have touched and improved the lives of countless Hoosiers. Her commitment to common sense care and high regard for patient dignity are well reflected in her legislative record.

 

“We are proud that Indiana has been so involved, informed, and well represented”, said Jones “and we are pleased to be able to recognize the contributions of Rep. Bucshon and Senator Miller”.   Previous recipients of IHIF’s Legislative Award include: State Representative. Ed Clere (2014), State Senator Brandt Hershman (2014), and U.S. Representative Susan W. Brooks (IN-5) (2015).

Rep. Larry Bucshon Official Photo
U.S. Rep. Larry Bucshon, M.D. (IN-8th)
Member of the House Energy &
Commerce Committee

PatMiller_2013

Senator Patricia Miller (District 32)
Assistant President Pro-Tempore

About IHIF

The Indiana Health Industry Forum (IHIF) is a statewide trade association representing members of Indiana’s health science business community.  The diverse members of IHIF generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.  For more information and to become a member, please visit www.ihif.org

 

###

 

February 2016 Life Science Lunch

February 16, 2016

Clinical Trials from a Study Site Perspective

The conduct of clinical research requires effective working relationships between the study sites that execute clinical trials and the sponsors that design the trials and provide product for testing. With much riding on study outcomes, understanding what happens behind the scenes may help you design more effective trials.  This month’s discussion will explore some of the bigger technical challenges to running a clinical research site, including:
•    Types of clinical trials, sponsors and study sites
•    Staffing/Workforce requirements,  needs, and challenges
•    Managing study site and sponsor expectations
•    Role of an IRB
•    Subject recruitment, screening, informed consent and enrollment
•    Managing costs

Moderator:

Deborah Pollack-Milgate, Partner

Barnes & Thornburg, LLP

Panelists:

Diana Caldwell

President and Founder

Pearl Pathways

Jenna Sallee

Executive Director

Orthopedic Research Foundation, Inc.

Dr. Scott Denne

Director

CTSI Clinical Research Center at IUPUI

About the Series

The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in life science. Each month, at lunch, a policymaker or a panel in the field of life science will be available to answer questions concerning the major challenges and opportunities in the life science industry. We hope you will join us.

There is no charge to attend, but please register so we know how many lunches to order. Please see registration page for details. Some of the discussion questions will be submitted to the speakers in advance.

For information on upcoming programs, please visit the Life Science Lunch website – http://www.ihif.org/pages/lifescience

Supporting Materials Mentioned in Today’s Discussion

New “Time Is Precious” Video from BIO

TIPIntro

Learn more at TimeIsPrecious.Life

“Research in Your Backyard: Developing Cures, Creating Jobs” PhRMA Report on Clinical Research in Indiana

IHIF 2016 Legislative Breakfast and Industry Briefing

January 18, 2016

 

An IHIF Signature Event

Presented by:

 Print     HWFH new logo     IMDMC 2013 Logo

You are Invited!

January 27, 2016

 

Downtown Indianapolis Hilton Hotel

120 W. Market Street

Monument Hall (Lower Level)

 

With Featured Speakers

Lt. Governor Sue Ellspermann

and

Rep. Ed Clere, House Public Health Committee

Due to a schedule change, Senator Pat Miller will be unable to join us for the program.  We are pleased to announce that Lt. Governor Sue Ellsperman will be with us to share her thoughts on the direction of the life science industry in Indiana.  Rep. Ed Clere will provide an assessment of the 2016 Legislative Session with special regard for public health matters.

Registration 7:15 am

Program 7:30 – 8:30 am

Welcome and Introduction

Kristin Jones, IHIF

  IMDMC Legislative Update

Kathy Heuer, Executive Director

“The Value of Medicines”

Saiza Elayda, PhRMA

The Indiana Health Industry Forum is a state-based trade association for members of Indiana’s health and life science manufacturing community.  The goal of the annual legislative breakfast briefing is to educate and engage IHIF members on Federal and State public policy issues and activities.  The event is open to member companies of IHIF, the Indiana Medical Device Manufacturers Council (IMDMC), the Hoosiers Work for Health/PhRMA task force, and all members of the Indiana General Assembly.  There is no charge to attend but please register.  For more information on IHIF, please visit www.ihif.org

 

Please register here to attend the breakfast briefing

IHIF Welcomes Mindray for First Discovery Days Program

January 7, 2016

 

Momentum Logo June 2014

Discovery Days

February 17-18, 2016

Mindray logo

 

The Indiana Health Industry Forum is pleased to announce that we have finalized dates for a company visit to Indiana by Mindray.   IHIF will be hosting company representatives here in Indianapolis on February 17th -18th for our first Discovery Days program!  Mindray representatives are interested in meeting Indiana businesses working in two areas: 1) in-vitro diagnostics and 2) assistive technologies, including health IT applications.  They are interested in meeting with both companies with established products looking to expand their market into China as well as identifying novel technologies that could use a developmental partner.   Mindray offers investment capital, assistance with CFDA approval, and joint venture opportunities.

About Mindray Medical International

Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. Over the last 17 years, we have become a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence. We are expanding our distribution network, sales and sales support staff to bring our products closer to end users. We currently have 29 local sales and service offices in China, as well as sales and service subsidiaries in Amsterdam, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver.   For more information, please visit http://www.mindraynorthamerica.com/about/

Apply to meet

If you have technologies or know of companies that may be interested in meeting with Mindray’s technology development representatives, please let us know!  IHIF is working to identify a pool of potential companies/technologies and then, working with Mindray, we’ll put together a short list of invitees to a 1-on-1 meeting with them here in Indianapolis.   Please submit a short (1 page) description of the company/technology to get things started.    Please submit descriptions to IHIF at info@ihif.org.   We will begin notifying accepted applicants by January 20th.

IHIF and Lodestone Insights Partner on New Member Benefit Program

November 1, 2015
ihif lodescore logo
The Indiana Health Industry Forum and Lodestone Insights are pleased to announce a partnership for the benefit of IHIF members.
Lodestone Insights (http://www.lodestoneinsights.com/) is the world’s only human curated and organized database of information and activities happening at conferences and symposia. We are tracking thousands of conferences in the healthcare, pharmaceuticals, science, diabetes, oncology, immunology, neuroscience, and technology sectors. Our clients leverage our Lodestone Insights products and services to make more informed strategic decisions.
Through Lodescore and our other products, managers, business development, competitive intelligence, due diligence, sales, marketing, and brand professionals are able to tap millions of points of data to:
  • Track their own brand presence and investments
  • Monitor thought leaders
  • Find new customers and partners
  • Pro-actively plan boots-on-the-ground conference strategies/tactics
  • Surface hot topics and trends in the market
  • Gain insights on their competitors
Lodescore is the first standardized scoring tool to shop and compare conferences. Save time and money and pick the right conferences to attend, speak, exhibit, and sponsor. Lodescore actively tracks over 4,000 conferences across the health science space and provides the details and analytics to help you make informed decisions on where to best spend your limited time, energy, and resources.
A free Lodescore demo is available on-line and there are multiple plan options to fit your needs and budget. IHIF Members are eligible for a 10% discount on current Lodestone Insight product rates.  
To request a member discount promo code, please contact IHIF.

Boehringer Ingelheim Day with MassBio

September 23, 2015

Boehringer Ingelheim Day with MassBio

2:00 – 7:30pm

MassBio and Catalyst restaurant at 300 Technology Square, Cambridge, MA 02139

October 8th, 2015

 

The Indiana Health Industry Forum has been invited to submit member profiles for consideration in the Boehringer Ingelheim Pharma Days program.  This event will be held in Boston, October 8th and is organized by MassBio – IHIF’s counterpart organization in Massachusetts.  If you would like to be considered for a one-on-one meeting with Boehringer Ingelheim, please submit a one-pager describing your program of interest to Kristin Jones at IHIF (kjones@ihif.org) by September 30th.  Please do not disclose confidential information. If selected, you must be able to travel to Boston on October 8th to participate in the meetings.

 *****

Please join us on Thursday, October 8th, 2015 for a private meeting and reception with a select group of MassBio members and senior leaders from Boehringer Ingelheim.

Boehringer Ingelheim will provide an overview of its Research & Development organization, Venture fund, therapeutic areas of interest and models for early and late stage licensing partnerships. There will be an opportunity to request one–to-one meetings. A poster competition and pitch contest will take place and a networking reception will follow the program. An innovation prize will be awarded to the winning start-up from the pitch contest at the reception.

One-on-one meetings may be requested by participants.

Boehringer Ingelheim will have teams within the following areas participating in one-on-one meetings: CNS, Oncology, Cardiometabolic, Immunology, Respiratory, Hearing loss, Microbiome, Regenerative medicine and Gene medicine.  For more details, see list below.

Agenda:

2:00 – 3:00pm               Registration and Poster presentation vote for Innovation Prize

Attendees will receive Massbio Dollars to invest into the top 3 most innovative technologies presented.

 

3:00 – 3:05pm               Welcome by MassBio Robert K. Coughlin, President and CEO at MassBio

 

3:05 – 3:30pm            Boehringer Ingelheim Partnering – Working Together for Better Health

  • Paola Casarosa, Corp VP, Business Development & Licensing/ Prescription Medicines

 

3:30 – 4:00pm            Discovery Research and External Innovation

  • Clive Wood, Corp Senior VP, Discovery Research

 

4:00 – 4:30pm            Boehringer Ingelheim Corporate Venture Fund

  • Frank Kalkbrenner, VP, Head of the Boehringer Ingelheim Venture Fund

 

4:30 – 5:00pm               Innovation Prize pitches and judging

 

5:00 – 5:30pm               Boehringer Ingelheim closing remarks and Q&A

 

5:30 –7:00pm                Reception – Catalyst
Innovation Prize winner will be announced at the reception

 

This event, part of the MassBio Pharma Day Series, will provide a great opportunity to network with Boehringer Ingelheim licensing and therapeutic area leaders and learn how a biopharmaceutical company evaluates external research and approaches licensing and partnerships.

 

Current Areas of Interest:

 

    • Central Nervous System
  • Alzheimer’s disease
  • Schizophrenia (focus: negative symptoms and/or cognitive impairment)
  • Depression (focus: treatment-resistant depression)
  • Impulse control disorders

Out of scope: Monoamine uptake inhibitors or monoamine receptor modulators, Compounds with undefined mechanism of action

    • Oncology
  • For clinical stage opportunities: Focus on lung cancer and haematology – irrespective of the MoA
  • Up to IND-ready stage:
  • Cancer cell -directed therapies
    • Growth signaling
    • Apoptosis regulation
    • Epigenetic regulation
    • Protein homeostasis
    • Additional areas of focus will emerge from scientific breakthroughs in cancer biology (e.g. genome integrity, splicing, protein translation, stem cell / developmental pathways, miRNAs)
  • Immune cell -directed therapies
    • Immune cell re-activation
    • Immune cell re-direction
    • Immune cell priming
    • Increased focus in the future will be on lymphocyte trafficking

 

  • Immunology
    • Crohn’s disease and ulcerative colitis
    • Systemic lupus erythematosus (including lupus nephritis)
    • Rheumatologic disorders such as RA (limited to mechanisms that show superior efficacy compared to current standard of care) and spondyloarthritis
    • Systemic sclerosis-scleroderma

Out of Scope: Microbial therapeutics and Gene therapy

 

  • Cardiometabolic
    • Chronic Kidney Diseases and Diabetic Nephropathy
    • Diabetic Retinopathy
    • NASH (Nonalcoholic steatohepatitis) and liver fibrosis
    • Obesity (CV-benefit and patient relevant weight loss >10%)
    • Type 2 Diabetes (evidence for disease modification, CV-risk reduction and/or significant weight reduction)

 

  • Respiratory
    • Chronic Obstructive Pulmonary Disease
    • Asthma
    • Interstitial Pulmonary Fibrosis
    • Cystic Fibrosis
    • Acute Lung Injury or Acute Respiratory Distress Syndrome

 

  • Research Beyond Borders
  • Microbiome:
    • Novel bacteria/bacterial products and their causal role in human health & disease (esp. related to autoimmune, CNS, oncology  and cardiometabolic disorders)
    • Microbiome triggers which impact host immune/inflammatory response & barrier function Depression (focus: treatment-resistant depression)
    • Elucidation of associated pathways & discrete targets (both host & microbiome-derived) for therapeutic intervention
  • Regenerative Medicine:
    • Molecular understanding of mechanisms involved in tissue degeneration
    • New targets or methods for identifying targets that are implicated in the mobilization and/or differentiation of endogenous stem cells/progenitor cells
    • Approaches that may modulate muscle/bone/cartilage degeneration, and/or neurodegeneration
  • Gene Therapy:
    • Rare diseases with high unmet medical need as entry, enabling BI to become a leader in the field; including proprietary assets available for potential partnering
    • Technology platform development, focusing on inducible system for regulatable expression of therapeutic products in the context of AAVs, ensuring applicability of gene therapies in nonlife-threatening diseases
  • Hearing Loss:
    • Understanding of mechanisms involved in hearing loss and approaches with potential to restore hearing or reduce loss
  • Age-related, as well as noise and drug-induced hearing loss

 

 

 

Boehringer Ingelheim Attendees:

 

Dr. Paola Casarosa, Corp. VP, Bus. Dev. & Licensing/Prescription Medicines

Dr. Monica Cheng, Global Licensing, Cardiometabolic Diseases, Bus. Dev. & Licensing/Prescription Medicines

Dr. Laurie Churchill, Global Head Immunology, Bus. Dev. & Licensing/Prescription Medicines

Dr. Henri Doods, VP, Research Beyond Borders

Dr. Jay Fine, Vice President & Global Therapeutic Area Head Immunology and Respiratory Diseases Research

Dr. Christine Grygon, Executive Director, Bus. Dev. & Licensing/Prescription Medicines

Dr. Martin Heidecker, Head of Venture Fund USA

Dr. Jullian Jones, Global Licensing, Oncology

Dr. Frank Kalkbrenner, VP, Venture Fund

Dr. Cyrille Kuhn, Executive Director, Head of Research Beyond Borders

Dr. Michael Mark, Global Head CardioMetabolic Diseases Research

Dr. Klaus Mendla, Global Head CNS, Bus. Dev. & Licensing/Prescription Medicines

Mr. Imran Nasrullah, Innovation Sourcing, Bus. Dev. & Licensing/Prescription Medicines

Dr. Chad Nivens, Global Head Respiratory, Bus. Dev. & Licensing/Prescription Medicines

Mr. Andrew Owenson, Corp. SVP, Therapeutic Area Head Respiratory

Dr. Michel Pairet, Corp. SVP, R&D non-clinical

Dr. Glyn Parkin, Corp. SVP, Therapeutic Area Head Cardiometabolic Diseases

Dr. Mark Pearson, VP, New Therapeutics Concept Discovery

Dr. Jan Poth, Therapeutic Area Head Immunology & Vice President Marketing, Pipeline Products

Mr. Ralph Mark, Director, External Partnerships and Financial Strategy

Dr. Juergen Reess, Therapeutic Area Head CNS

Dr. Oliver Reuss, Head of Business Model & HealthCare Innovation

Dr. Ioannis Sapountzis, Global Head Oncology, Bus. Dev. & Licensing/Prescription Medicines

Prof. Dr. Gerd Schnorrenberg, Senior Executive Advisor, R&D non-clinical

Dr. Margrit Schwarz, VP, Cardiometabolic Diseases Research

Dr. Peter Seither, Senior Manager, Scientific Collaborations

Dr. Bernd Sommer, Head of CNS Research

Dr. Georg van Husen, Therapeutic Area Head Cardiovascular

Dr. Clive Wood, Corp. SVP, Discovery Research

Dr. Johannes Zanzinger, Global Head Cardiometabolic Diseases, Bus. Dev. & Licensing/Prescription Medicines